Rituximab and FAB/LMB 96 Chemotherapy in Children With Stage III/IV B-Cell Non-Hodgkin Lymphoma: A Children’s Oncology Group Report
Leukemia - United Kingdom
doi 10.1038/leu.2012.255
Full Text
Open PDFAbstract
Available in full text
Date
September 3, 2012
Authors
Publisher
Springer Science and Business Media LLC